Euroapi

Green Chemistry And Domestic Sourcing Will Unlock Secular Demand

AnalystHighTarget

Not Invested

Consensus Narrative from 5 Analysts

Published

09 Aug 25

Updated

16 Aug 25

AnalystHighTarget's Fair Value

€3.50

11.4% undervalued

16 Aug

€3.10

-27.9%

5.7%

Author's Valuation

€3.5

11.4% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

€3.5

11.4% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

1.23%

Pharma revenue growth rate

1.05%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.98%

Calculation

€17.51m

Earnings '28

22.60x

PE Ratio '28

€395.79m

Market Cap '28

€395.79m

Market Cap '28

95.07m

No. shares '28

€4.16

Share Price '28

€4.16 Share Price '28

Discounted to 2025 @ 5.98% p.a.

€3.50

Fair Value '25